Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
Open | $12.51 |
Close | - |
Volume / Avg. | 3.89K / 70.02K |
Day Range | 12.51 - 12.99 |
52 Wk Range | 10.00 - 24.40 |
Market Cap | $58.89M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 2.84% |
Days to Cover | 1.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cidara Therapeutics (NASDAQ:CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for Cidara Therapeutics.
Cidara Therapeutics has a consensus price target of $19.75.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $12.91 last updated Today at July 17, 2024 at 11:54 AM EDT.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Cidara Therapeutics.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.